News
Cancer Dx Firm Pillar Biosciences Gets $18M Investment From ORI Healthcare
NEW YORK (GenomeWeb) – Hong Kong-based venture capital group ORI Healthcare Fund announced today that it has made an $18 million investment in Boston-based cancer molecular diagn
Work With Us
Whether you are looking for funding, have a press inquiry, or want to become a community partner, we’d love to hear from you.